Silverback Therapeutics Inc

$9.19 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Silverback Therapeutics Inc

Silverback Therapeutics, Inc. operates as a biotechnology company. The Company discovers and develops novel and proprietary ImmunoTAC technology, which is designed to create potent therapeutic molecules that can be systemically administered to patients. Silverback Therapeutics serves customers worldwide.

Stock Analysis

last close $9.19
1-mo return -22.9%
3-mo return -71.8%
avg daily vol. 464.63T
52-week high 63.41
52-week low 9.1
market cap. $345M
forward pe -
annual div. -
roe -20.3%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 86.3%
baraka

Subscribe now for daily local and international financial news

Subscribe